← Back to directory

Francesc Artigas

Researcher Next ID · RN-035440

Researcher · Biochemistry, Genetics and Molecular Biology

Instituto de Salud Carlos III

Madrid, Spain

Accepting doctoral researchersFunding unknown
Works count
694
Citation count
19,132
H-index
76
i10-index
231

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Neuroscience
Neurotransmitter Receptor Influence on Behavior
Neuroscience and Neuropharmacology Research
Treatment of Major Depression
Receptor Mechanisms and Signaling
Tryptophan and brain disorders

Publications

  • Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data

    Pharmacology & Therapeutics · 2014 · 10.1016/j.pharmthera.2014.07.001

  • Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research

    CNS Drugs · 2013 · 10.1007/s40263-013-0071-0

  • Serotonin modulation of cortical neurons and networks

    DOAJ (DOAJ: Directory of Open Access Journals) · 2013 · https://doi.org/10.3389/fnint.2013.00025

  • Serotonin receptors involved in antidepressant effects

    Pharmacology & Therapeutics · 2012 · 10.1016/j.pharmthera.2012.09.006

  • A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder

    The International Journal of Neuropsychopharmacology · 2011 · 10.1017/s1461145711001027

  • Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression

    The International Journal of Neuropsychopharmacology · 2011 · 10.1017/s1461145711001088

  • Quantitative Analysis of the Expression of Dopamine D1 and D2 Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex

    Cerebral Cortex · 2008 · 10.1093/cercor/bhn134

  • The Hallucinogen DOI Reduces Low-Frequency Oscillations in Rat Prefrontal Cortex: Reversal by Antipsychotic Drugs

    Biological Psychiatry · 2008 · https://doi.org/10.1016/j.biopsych.2008.03.013

  • Clozapine and Haloperidol Differently Suppress the MK-801-Increased Glutamatergic and Serotonergic Transmission in the Medial Prefrontal Cortex of the Rat

    Neuropsychopharmacology · 2007 · 10.1038/sj.npp.1301356

  • Involvement of 5-HT1AReceptors in Prefrontal Cortex in the Modulation of Dopaminergic Activity: Role in Atypical Antipsychotic Action

    Journal of Neuroscience · 2005 · 10.1523/jneurosci.2999-05.2005

  • The activation of 5‐HT2A receptors in prefrontal cortex enhances dopaminergic activity

    Journal of Neurochemistry · 2005 · 10.1111/j.1471-4159.2005.03485.x

  • The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems

    Neuroscience & Biobehavioral Reviews · 2004 · 10.1016/j.neubiorev.2004.05.001

  • The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.

    PubMed · 2004

  • The therapeutic role of 5-HT1A and 5-HT2A receptors in depression

    Journal of Psychiatry and Neuroscience · 2004 · 10.1139/jpn.0427

  • Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei

    Brain Research Reviews · 2002 · 10.1016/s0165-0173(02)00182-0

  • Control of Serotonergic Function in Medial Prefrontal Cortex by Serotonin-2A Receptors through a Glutamate-Dependent Mechanism

    Journal of Neuroscience · 2001 · https://doi.org/10.1523/jneurosci.21-24-09856.2001

  • How does pindolol improve antidepressant action?

    Trends in Pharmacological Sciences · 2001 · 10.1016/s0165-6147(00)01682-5

  • Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors

    Journal of Neuroscience · 2001 · https://doi.org/10.1523/jneurosci.21-24-09917.2001

  • Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

    The Lancet · 1997 · https://doi.org/10.1016/s0140-6736(96)08007-5

  • Comparative Study in the Rat of the Actions of Different Types of Stress on the Release of 5-HT in Raphe Nuclei and Forebrain Areas

    Neuropharmacology · 1997 · 10.1016/s0028-3908(97)00048-8

  • Role of 5‐HT1Aautoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies

    Fundamental and Clinical Pharmacology · 1996 · 10.1111/j.1472-8206.1996.tb00145.x

  • Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists

    Trends in Neurosciences · 1996 · 10.1016/s0166-2236(96)10037-0

  • Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

    Archives of General Psychiatry · 1994 · 10.1001/archpsyc.1994.03950030084009

  • 5-HT and antidepressants: new views from microdialysis studies

    Trends in Pharmacological Sciences · 1993 · 10.1016/0165-6147(93)90125-4

  • Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei

    Synapse · 1993 · 10.1002/syn.890150310

  • Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study

    European Journal of Pharmacology · 1992 · 10.1016/0014-2999(92)90292-c

  • Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex

    Naunyn-Schmiedeberg s Archives of Pharmacology · 1991 · 10.1007/bf00251121

Current projects

    No projects listed.